Altoida is a technology company specializing in the development of digital biomarkers for neurological diseases, utilizing augmented reality and machine learning. The platform provides an objective assessment of neurological health, which enhances patient selection and monitoring in clinical trials. Altoida aims to deliver actionable insights to life sciences firms, facilitating the development of novel therapeutics and advancing the field of precision neurology. With over two decades of scientific research backing its proprietary platform, Altoida's work has been recognized in various peer-reviewed publications. The company fosters a culture centered around six core principles: Patient-First, Open Communication, Collaboration, Reliability, Embracing Positive Change, and Thinking and Building at Scale. This ethos is integral to their commitment to improving the success rates of clinical outcomes and enhancing patient care in neurology.